BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Arrhythmia Research Technology, Inc. Announces Fourth Quarter and Year End Results

  March 24, 2009

   · 

  5 min read
• Business

  CDEX Inc. CEO Provides an Updated Management Briefing; Dr. Wade Poteet Transitions From Principal Scientist to Project Consultant

  March 24, 2009

   · 

  2 min read
• BioMidwest

  Myriad Genetics, Inc. to Present at Citi’s 4th Annual Biotech Day on April 1, 2009

  March 24, 2009

   · 

  2 min read
• Business

  MethylGene Fourth Quarter and Full Year 2008 Results Conference Call Notice

  March 24, 2009

   · 

  4 min read
• Business

  ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region

  March 24, 2009

   · 

  2 min read
• Business

  Biovitrum AB Gets Access to Affibody Technology

  March 24, 2009

   · 

  3 min read
• BioMidwest

  Aastrom Biosciences, Inc. Receives Notification That NASDAQ Further Extends Suspension of Certain Continued Listing Requirements

  March 24, 2009

   · 

  1 min read
• Drug Development

  Vical Incorporated’s Allovectin-7(r) Phase 3 Trial Receives Positive Review From Safety Monitoring Board

  March 24, 2009

   · 

  1 min read
• Bio NC

  Argos Therapeutics, Inc. Presents Research on the Development and Evaluation of Immunotherapies for HIV

  March 24, 2009

   · 

  1 min read
• Business

  Traversa Therapeutics, Inc. Announces Appointment of William G. Kaelin, Jr., M.D. and Yitzhak Tor, Ph.D. to the Company’s Scientific Advisory Board

  March 24, 2009

   · 

  1 min read